Melabiorytm

Melatonin, the active ingredient in Melabiorytm, is a melatonin receptor agonist presented as an oral tablet for oral use. It is used to help manage insomnia, circadian rhythm sleep disorders and jet lag in adults and, where appropriate, in pediatric patients.

GNH USA supplies Melabiorytm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU quality standards, is packaged in tamper‑evident containers and is distributed under strict regulatory compliance.

Melabiorytm, a melatonin receptor agonist, is indicated for disorders affecting the sleep‑wake cycle.

Insomnia: facilitates sleep onset and improves sleep continuity in individuals with difficulty falling asleep. Circadian rhythm sleep disorders: helps realign the internal clock in shift‑work or delayed‑sleep‑phase conditions. Jet lag: reduces the time required to adjust to new time zones after rapid east‑west travel.

Oral melatonin may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Drowsiness or daytime sleepiness - Headache - Nausea - Dizziness

Serious or Rare Side Effects: - Allergic skin reactions (rash, pruritus) - Severe hypersensitivity (anaphylaxis) - Mood changes (depression, agitation)

When considering melatonin therapy, several safety aspects should be reviewed.

Assess underlying conditions: evaluate for depression, seizure disorders, or autoimmune disease before use. Review concomitant medications: consider potential interactions with anticoagulants, immunosuppressants, or central nervous system depressants. Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. Age considerations: dose adjustments may be needed for children and the elderly. Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and direct light.

Melatonin can influence the activity of several other medicines; interactions are classified by clinical significance.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): melatonin may enhance anticoagulant effect, increasing bleeding risk. - Immunosuppressants (e.g., cyclosporine): may reduce immunosuppressive efficacy.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, antihistamines): additive sedative effect, monitor drowsiness. - CYP1A2 substrates (e.g., theophylline, fluvoxamine): melatonin can inhibit metabolism, adjust dose if needed. - Hormonal contraceptives: possible reduction in efficacy, monitor menstrual changes.